Manuscripts
Showing 1554 manuscripts.
Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action
Citation
Angela Colbers, Françoise Renaud, Alexandra Calmy, Polly Clayden, Marissa Vicari, Imelda C Mahaka, Jennifer M Zech, Cadi Irvine, Elaine J Abrams, Participants of the WHO-IMPAACT Workshop “Approaches to Enhance and Accelerate Study of New Drugs for HIV and Associated Infections in Pregnant Women”, Martina Penazzato, Shahin Lockman. Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action. Journal of the International AIDS Society. 2022. 25: e25912. PMID: 35851834Year
2022
Journal
Journal of the International AIDS Society
Caregiver willingness to give TPT to children living with drug-resistant TB patients
Citation
S Kim, L Naini, J Shenje, E Mitchell, M Raesi, M Lourens, A Mendoza, F Conradie, N Suryavanshi, M Hughes, S Shah, G Churchyard, S Swindells, A Hesseling, V Rouzier, A Gupta, M Murrill. Caregiver willingness to give TPT to children living with drug-resistant TB patients. International Journal of Tuberculosis and Lung Disease. 2022. 26: 949-955. PMID: 36163664Year
2022
Journal
International Journal of Tuberculosis and Lung Disease
Study
IMPAACT 2003/ACTG 5300
Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens
Citation
Camlin Tierney, Sharon Huang, Marion Peters, Tsungai Chipato, Frances Martinson, Neaka Mohtashemi, Dingase Dula, Kathy George, Nahida Chaktoura, Karin L Klingman, Devasena Gnanashanmugam, Judith S Currier, Mary G Fowler, Debika Bhattacharya, Amita Gupta. Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens. Clinical Infectious Diseases. 2021. 72: 1342-1349. PMID: 32161944Year
2021
Journal
Clinical Infectious Diseases
Study
1077BF, 1077FF
Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy
Citation
Lee Fairlie, Mauricio Pinilla, Katie McCarthy, Maxensia Owor, Lameck Chinula, Bonus Makanani, Avy Violari, Dhayendre Moodley, Nahida Chakhtoura, Renee Browning, Risa Hoffman, MG Fowler, Gerhard Theron, Sean Brummel. Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy. Clinical Infectious Diseases. 2021. 73: e312-e320. PMID: 32564058Year
2021
Journal
Clinical Infectious Diseases
Study
1077BF, 1077FF
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis
Citation
Edward P Acosta, Jack Moye, Ellen Townley, Sarah Bradford, Emily Brown, Kayla Denson, Bobbie Graham, Laura Hovind, Thucuma Sise, Hedy Teppler, Sisinyana Ruth Mathiba, Lee Fairlie, Jana L Winckler, Gretchen Slade, Paul Krogstad, Tammy Meyers, Pearl Samson, International Maternal Pediatric Adolescent AIDS Clinical Trials Network P1101 Team. Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. Journal of Pediatric Infectious Disease Society. 2021. PMID: 32448902Year
2021
Journal
Journal of Pediatric Infectious Disease Society
Study
P1101
Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women with HIV
Citation
IMPAACT P1078 study team, Jyoti S Mathad, Sylvia M LaCourse, Marie F Pierre, Timothy R Sterling, David W Haas, Shilpa Naik, Enid Kabugho, Gaerolwe Masheto, Savita Pahwa, Katie McCarthy, Sarah Bradford, Gerhard Theron, Adriana Weinberg, Diane Costello, Lisa Aaron, Bonnie Zimmer, Grace Montepiedra, Kamunkhwala Gausi, Renee Browning, Paolo Denti, Blandina Mmbaga, Tichaona Vhembo, Amita Gupta. Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women with HIV. Clinical Infectious Diseases. 2021. 73: e3555-e3562. PMID: 32720695Year
2021
Journal
Clinical Infectious Diseases
Study
P1078
Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency Virus
Citation
Nahida Chakhtoura, Amy James Loftis, Tsungai Chipato, Teacler Nematadzira, Mandisa Nyati, Carolyne Onyango-Makumbi, Gaerolwe Masheto, James Ngocho, Fuanglada Tongprasert, Sandesh Patil, Gerhard Theron, Dominique Lespinasse, Grace Montepiedra, Adriana Weinberg, Lisa Aaron, Amita Gupta, Katie McCarthy, IMPAACT P1078 TB APPRISE Study Team, Patrick Jean-Philippe, Bonnie Zimmer. Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency Virus. Clinical Infectious Diseases. 2021. 72: 784-790. PMID: 32997744Year
2021
Journal
Clinical Infectious Diseases
Study
P1078
Using a Composite Maternal-Infant Outcome Measure in Tuberculosis-Prevention Studies Among Pregnant Women
Citation
Nahida Chakhtoura, Patrick Jean-Philippe, Scott Evans, Amita Gupta, Grace Montepiedra, Soyeon Kim, Adriana Weinberg, Gerhard Theron, Timothy R Sterling, Sylvia M LaCourse, Sarah Bradford. Using a Composite Maternal-Infant Outcome Measure in Tuberculosis-Prevention Studies Among Pregnant Women. Clinical Infectious Diseases. 2021. 73PMID: 33146706Year
2021
Journal
Clinical Infectious Diseases
Study
P1078
Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping
Citation
Renee Browning, Mercy Mutambanengwe, Nahida Chakhtoura, Vongai Chanaiwa, Grace Montepiedra, Mandisa Nyati, Lisa Aaron, Tsungai Mhembere, Katie McCarthy, Fuanglada Tongprasert, Sarah Bradford, Anneke Hesseling, Tichaona Vhembo, Katherine Shin, Lynda Stranix-Chibanda, Bonnie Zimmer, Gaerolwe R Masheto, Diane Costello, Kamunkhwala Gausi, Avy Violari, Patrick Jean-Philippe, Lubbe Wiesner, Blandina T Mmbaga, Timothy R Sterling, Jennifer Norman, Linda Aurpibul, Gerhard Theron, Carole L Wallis, Ramesh Bhosale, Adriana Weinberg, Carolyne Onyango-Makumbi, Neetal Nevrekhar, Amita Gupta, Tsungai Chipato, Vanessa Rouzier, Paolo Denti, David W Haas, Enid Kabugho, IMPAACT P1078 (TB APPRISE) Study Group Team. Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping. Clinical Pharmacology & Therapeutics. 2021. 109: 1034-1044. PMID: 32909316Year
2021
Journal
Clinical Pharmacology & Therapeutics
Study
P1078
Safety and Efficacy of 48 and 96 Weeks of Alendronate in Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection and Low Bone Mineral Density for Age
Citation
Hans M Spiegel, Catherine M Gordon, Rohan Hazra, George K K Siberry, Jane C Lindsey, Denise L Jacobson. Safety and Efficacy of 48 and 96 Weeks of Alendronate in Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection and Low Bone Mineral Density for Age. Clinical Infectious Diseases. 2021. 72: 1059-1063. PMID: 32584996Year
2021
Journal
Clinical Infectious Diseases
Study
P1076